26 phenotypes from 2 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Prlhtm1Taon/Prlhtm1Taon B6N.129X1-Prlhtm1Taon	abnormal autonomic nervous system physiology	J:144729
	normal behavior/neurological phenotype	J:144729
	hepatic steatosis	J:144729
	normal homeostasis/metabolism phenotype	J:144729
	impaired glucose tolerance	J:144729
	increased body weight	J:144729
	increased brown adipose tissue amount	J:144729
	increased circulating insulin level	J:144729
	increased circulating leptin level	J:144729
	increased circulating triglyceride level	J:144729
	increased compensatory feeding amount	J:144729
	increased fat cell size	J:144729
	increased food intake	J:144729
	increased liver triglyceride level	J:144729
	increased susceptibility to diet-induced obesity	J:144729
	increased white adipose tissue amount	J:144729
	insulin resistance	J:144729
	obese	J:144729
Prlhtm2Smln/Prlhtm2Smln involves: C57BL/6J	abnormal body temperature homeostasis	J:215557
	abnormal response/metabolism to endogenous compounds	J:215557
	decreased core body temperature	J:215557
	normal homeostasis/metabolism phenotype	J:215557
	hyperglycemia	J:215557
	increased body weight	J:215557
	increased circulating insulin level	J:215557
	increased circulating leptin level	J:215557
	increased epididymal fat pad weight	J:215557
	increased food intake	J:215557
	increased subcutaneous adipose tissue amount	J:215557
	increased susceptibility to diet-induced obesity	J:215557
	increased total body fat amount	J:215557
	obese	J:215557
Prlhtm2Smln/Prlhtm2Smln 7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+ involves: C57BL/6 * C57BL/6J * SJL	abnormal body temperature homeostasis	J:215557
	abnormal response/metabolism to endogenous compounds	J:215557
	normal growth/size/body region phenotype	J:215557
Prlhtm2Smln/Prlhtm2Smln Tg(Nes-cre)1Kln/0 involves: C57BL/6 * C57BL/6J * SJL	normal behavior/neurological phenotype	J:215557
	normal growth/size/body region phenotype	J:215557
	normal homeostasis/metabolism phenotype	J:215557